A panelist discusses how tumor heterogeneity (both spatial and temporal) affects molecular testing reliability in ovarian cancer, highlighting that although most biomarkers show little heterogeneity, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback